Megacal-M Solution For Injection
Revised: January 2015
(Minor Typographical errors)
AN: 01339/2007
SUMMARY OF PRODUCT CHARACTERISTICS
1. NAME OF THE VETERINARY MEDICINAL PRODUCT
Megacal-M Solution for Injection
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
Active Substance:
Calcium (as Calcium Gluconate) 4.6g/100ml
Magnesium (as Magnesium Hypophosphite) 0.8g/100ml
Excipient:
Boric Acid 10.0g/100ml
For the full list of excipients, see section 6.1
3. PHARMACEUTICAL FORM
Solution for injection
A colourless to pale yellow solution
4. CLINICAL PARTICULARS
4.1 Target Species:
Cattle
Indications for use, specifying the target species
For treatment of hypocalcaemia and as an aid in raising blood magnesium levels where a deficiency may be expected.
4.3 Contra-indications
Known hypersensitivity to the to the active ingredients.
Known cases of cardiac arrhythmia or severe toxaemia
4.4 Special warnings for each target species
The product should be administered with care particularly where concurrent toxaemia exists. In recumbent cows with poor peripheral circulation, administer appropriate calcium therapy intravenously.
4.5 Special precautions for use
Warm the product to body temperature before administration.
When the intravenous route is being used, extreme caution must be taken to ensure slow administration.
This product does not contain an antimicrobial preservative. Any solution remaining in the vial after withdrawal of the required dose should be discarded.
Special precautions to be taken by the person administering the product to animals
Care should be taken to avoid accidental self-injection. If accidental self-injection occurs, seek medical advice.
Eye Contact: immediately flush the eye with copious amounts of clean running water.
Skin contact: Wash the affected area thoroughly. If irritation occurs seek medical advice.
Ingestion: If accidentally swallowed, seek urgent medical attention and show product label and / or pack insert to the doctor.
ADVICE TO DOCTOR: For treatment advice contact the National Poisons Information Service (NPIS) or your local Poisons Information Centre.
4.6 Adverse reactions (frequency and seriousness)
None known
4.7 Use during pregnancy, lactation or lay
Safe for use during pregnancy and lactation
4.8 Interaction with other medicinal products and other forms of interaction
None known.
4.9 Amounts to be administered and administration route
By subcutaneous or slowintravenous injection.
Cattle – 100 - 200ml.
Large volumes should be divided between multiple sites. Massage sites gently.
4.10 Overdose (symptoms, emergency procedures, antidotes), if necessary
The product is for treatment of acute deficiency in a life threatening situation and overdosage within the recommended guidelines is unlikely.
4.11 Withdrawal period(s)
Meat – Zero days
Milk – Zero hours
5. PHARMACOLOGICAL PROPERTIES
This product is intended to restore blood calcium levels in cases of hypocalcaemia.
6. PHARMACEUTICAL PARTICULARS
6.1 List of Excipients
Boric Acid
Water for Injection
Sodium Hydroxide (For pH adjustment)
Acetic Acid (For pH adjustment)
6.2 Major incompatibilities
None known
6.3 Shelf life
Shelf life of the veterinary medicinal product as packaged for sale:
3 years.
Special precautions for storage
Store below 25°C. Protect from light.
Nature and composition of immediate packaging
A 100ml clear glass vial with nitryl rubber bung and gold seal containing a clear, colourless to pale yellow sterile solution
Special precautions for the disposal of unused veterinary medicinal product or waste materials derived from the use of such products, if appropriate
Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed if in accordance with local requirements.
7. MARKETING AUTHORISATION HOLDER
Ballinskelligs Veterinary Products,
Ballinskelligs,
Co. Kerry,
Ireland.
8. MARKETING AUTHORISATION NUMBER
Vm 12828/4000
9. DATE OF FIRST AUTHORISATION
01 February 1999
10. DATE OF REVISION OF THE TEXT
January 2015
Approved: 29 January 2015
Page 4 of 4